BNIP3 and BNIP3L were overexpressed in HCC-SR cells, and the therapeutic efficacy of sorafenib was evaluated by performing CCK-8, clone formation and Annexin V/PI assays. This evidence concerns the gene ANXA5 and hepatocellular carcinoma.